In my view, the next big announcement shall be a big pharma partner for COVID-19. The last 4C put the discussions ongoing for at least a month. During the last conf call, the CFO refused to get drawn into a discussion or answer the analyst question on funds allocated for manufacturing in next quarters. Maybe the last fresh equity funds raise put the company in a better negotiation position, but won’t actually be needed for manufacturing if there is a big pharmaceutical partnership....
Here is an excerpt from MESOBLAST’s last 4C: “Mesoblast is in active discussions with US and other government authorities as well as potential pharmaceutical partners with respect to its plans for ramp-up of commercial manufacturing for remestemcel-L in COVID-19 ARDS.”
http://investorsmedia.mesoblast.com/static-files/04851ade-aca5-492c-9784-45ae8c772f04
- Forums
- ASX - By Stock
- Ann: Remestemcel-L Improves Outcomes in Inflammatory Lung Disease
In my view, the next big announcement shall be a big pharma...
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.03 |
Change
-0.025(2.38%) |
Mkt cap ! $1.170B |
Open | High | Low | Value | Volume |
$1.06 | $1.06 | $1.02 | $5.734M | 5.571M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
14 | 203347 | $1.02 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.03 | 125348 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
14 | 203347 | 1.020 |
12 | 412127 | 1.015 |
12 | 92894 | 1.010 |
6 | 80671 | 1.005 |
27 | 111616 | 1.000 |
Price($) | Vol. | No. |
---|---|---|
1.030 | 125348 | 6 |
1.035 | 96469 | 8 |
1.040 | 25000 | 2 |
1.045 | 31585 | 4 |
1.050 | 70234 | 5 |
Last trade - 16.10pm 16/05/2024 (20 minute delay) ? |
|
|||||
Last
$1.03 |
  |
Change
-0.025 ( 2.94 %) |
|||
Open | High | Low | Volume | ||
$1.06 | $1.06 | $1.02 | 953870 | ||
Last updated 15.59pm 16/05/2024 ? |
Featured News
MSB (ASX) Chart |